Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00736229 · ClinicalTrials.gov registry record · Phase 4
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
A Phase 4 study, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00736229 is a Phase 4 study that has completed, run by Saint Luke's Health System. The registered enrollment target is 40 participants.
The verdict
NCT00736229, a Phase 4 study, has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of intravenous Exenatide therapy in hyperglycemic patients admitted to the coronary intensive care unit.
Interventions
- DRUG Exenatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00736229
The ClinicalTrials.gov registry entry for NCT00736229 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exenatide is the first listed.
NCT00736229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00736229 about?
NCT00736229 is a clinical study titled "Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients". The purpose of this study is to determine the efficacy of intravenous Exenatide therapy in hyperglycemic patients admitted to the coronary intensive care unit.
What is the current status of trial NCT00736229?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2008-08. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00736229?
The interventions under investigation include: Exenatide (DRUG).
Who is sponsoring clinical trial NCT00736229?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.